Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending March 5 2023

Healthcare Private Placement and M&A Transactions Review Week Ending March 5 2023

by Jonathan Hodson-Walker | Mar 8, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Cargo Therapeutics: The company raised $200 million of Series A1 venture funding in a deal led by Third Rock Ventures, Xontogeny, and RTW Investments on March 1, 2023, putting the...
Consumer Private Placement and M&A Transactions Review Week Ending March 5 2023

Consumer Private Placement and M&A Transactions Review Week Ending March 5 2023

by Jonathan Hodson-Walker | Mar 8, 2023 | Consumer

Strategy | Financing Highlight  Private Placement / Financing Transactions Foxtrot: The company raised $18.6 million of venture funding in the form of convertible debt from undisclosed investors on February 27, 2023. The company is an operator of a retail platform...
Technology Private Placement and M&A Transactions Review Week Ending February 26 2023

Technology Private Placement and M&A Transactions Review Week Ending February 26 2023

by Jonathan Hodson-Walker | Mar 1, 2023 | Technology

Strategy | Financing Highlight  Private Placement / Financing Transactions Tome: The company raised $43 million of Series B venture funding in a deal led by Lightspeed Venture Partners on February 22, 2023, putting the company’s pre-money valuation at $257...
Healthcare Private Placement and M&A Transactions Review Week Ending February 26 2023

Healthcare Private Placement and M&A Transactions Review Week Ending February 26 2023

by Jonathan Hodson-Walker | Mar 1, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Capsida Biotherapeutics: The company raised $70 million of venture funding from AbbVie on February 23, 2023. The company is a developer of targeted gene therapies intended to treat debilitating...
Consumer Private Placement and M&A Transactions Review Week Ending February 26 2023

Consumer Private Placement and M&A Transactions Review Week Ending February 26 2023

by Jonathan Hodson-Walker | Mar 1, 2023 | Consumer

Strategy | Financing Highlight  Private Placement / Financing Transactions Choco: The company raised EUR 25 million of venture funding from Coatue Management, Insight Partners, and Left Lane Capital on February 23, 2023. G Squared and Bessemer Venture Partners also...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending October 19, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending October 19, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending October 19, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending October 12, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending October 12, 2025

Categories

Archives